Cardiometabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases
Abstract
Review article concerning the individual cardiometabolic risk assessment as the basic approach in the personalized primary prevention of cardiovascular diseases and type 2 diabetes. Cardiometabolic biomarkers, which could improve cardiometabolic risk prediction, are summarized.